NDT Pharmaceuticals Inc. NDTP
0.11 USD 0.00 (-1.47%)
At close·Nov 2, 2026, 4:00 PM EST
0.0646 52-week range 2.10
- YTD
- -93.94%
- 1 year
- -88.50%
Altman Z-Score
12.71 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
P/E -11547×
P/S 0.0×
P/B 5712×
P/FCF 0.0×
EV/EBITDA -11547×
EV/Sales 0.0×
FCF Yield 0.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -49.5%
ROIC -49.5%
ROA -15.8%
Revenue 0.0%
Operating Income -36.7%
EPS (diluted) 100.0%
Free Cash Flow 0.0%
Current Ratio 0.0×
Quick Ratio 0.0×
Debt / Equity 0.0×
Net Debt / EBITDA 0.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31